EAACI Congress 2023
BackAtopic and contact Dermatitis: What’s new?
Sunday 11 Jun, 15:45 PM -
17:15 PM CEST
15:45
Safety of upadacitinib in moderate-to-severe atopic dermatitis
16:15
New Key Players in Irritant Contact Dermatitis: Residential Skin Cells and Neutrophils Drive Inflammation
16:45
Real-world study of dupilumab in adults with atopic dermatitis
